22157.jpg
Global Checkpoint Inhibitors Market (2021 to 2030) - Featuring AstraZeneca, Roche Holding and Pfizer Among Others
December 07, 2021 06:58 ET | Research and Markets
Dublin, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. This...
22157.jpg
Global Head and Neck Squamous Cell Carcinoma Drug Market Report 2021: Limited R&D in HNSCC, Resulting in a Market with Little Competition and a Stagnant Pipeline - Market Will Grow to $5.2B in 2030
November 08, 2021 05:53 ET | Research and Markets
Dublin, Nov. 08, 2021 (GLOBE NEWSWIRE) -- The "Head and Neck Squamous Cell Carcinoma - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering....
22157.jpg
Global Neuroendocrine Tumors Market & Drug Forecast 2021-2030 | Most Important Unmet Needs and the Projected Impact of 5 Late-Stage Pipeline Agents Entering the Market
October 14, 2021 07:13 ET | Research and Markets
Dublin, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The "Neuroendocrine Tumors - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. The market of...
22157.jpg
Worldwide Oncology Pharmaceuticals Industry to 2026 - Robust Approval of Oncology Pharmaceuticals is Driving Growth
October 06, 2021 07:13 ET | Research and Markets
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Pharmaceuticals Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for oncology...
AzurRx_Logo_CMYK.jpg
AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma
September 14, 2021 07:30 ET | AzurRx BioPharma, Inc.
BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...
22157.jpg
Global Checkpoint Inhibitor Refractory Cancer Market Report 2021: Marketed Therapies, Emerging Therapies, Checkpoint Inhibitors, Major Markets, Epidemiology - Forecast to 2030
August 17, 2021 03:38 ET | Research and Markets
Dublin, Aug. 17, 2021 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitor Refractory Cancer - Market Insights, Epidemiology and Market Forecast 2030" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global Peptide Based Cancer Therapeutics Market Share, Size, Trends Analysis Report, Featuring AstraZeneca PLC, Abbott, Allergan plc and Pfizer Inc.
April 27, 2021 04:38 ET | Research and Markets
Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The "Peptide Based Cancer Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Type; By Cancer Type; By Mode of Mechanism, By...
22157.jpg
United States Cancer Antibody Market, Drug Price, Sales & Clinical Trials Insight 2021-2026
April 14, 2021 04:18 ET | Research and Markets
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "US Cancer Antibody Market, Drug Price, Sales & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. Over...
AzurRx_Logo_CMYK.jpg
AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for Grade 1 Immune Checkpoint Inhibitor-Associated Colitis
April 13, 2021 08:30 ET | AzurRx BioPharma, Inc.
DELRAY BEACH, Fla., April 13, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development...
22157.jpg
Insights on the Cancer Biological Toxins Drug Global Market to 2026 - by Phase, Status, Cancer Type and Countries
February 04, 2021 07:48 ET | Research and Markets
Dublin, Feb. 04, 2021 (GLOBE NEWSWIRE) -- The "Global Cancer Biological Toxins Drug Market Opportunity, Drug Sales & Clinical Trials Insight 2026" report has been added to...